Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05471947 · ClinicalTrials.gov registry record · Phase 4
TCA 15% Chemical Peel for Improvement in Hand Lentigines
A Phase 4 study, sponsored by Main Line Center for Laser Surgery.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT05471947 is a Phase 4 study that has completed, run by Main Line Center for Laser Surgery. The registered enrollment target is 20 participants.
The verdict
NCT05471947, a Phase 4 study, has completed, sponsored by Main Line Center for Laser Surgery.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of the a 15% trichloroacetic acid + 3% glycolic acid peel combination for treatment of lentigines on the hands. This peel combination is sold over the counter. Patients will receive 3 treatments (spaced 4 weeks).
Interventions
- DRUG 15% Trichloroacetic acid + 3% glycolic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2024-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05471947
The ClinicalTrials.gov registry entry for NCT05471947 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Main Line Center for Laser Surgery, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 15% Trichloroacetic acid + 3% glycolic acid is the first listed.
NCT05471947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05471947 about?
NCT05471947 is a clinical study titled "TCA 15% Chemical Peel for Improvement in Hand Lentigines". This study will evaluate the efficacy of the a 15% trichloroacetic acid + 3% glycolic acid peel combination for treatment of lentigines on the hands. This peel combination is sold over the counter. Patients will receive 3 treatments (spaced 4 weeks).
What is the current status of trial NCT05471947?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2023-03-15. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT05471947?
The interventions under investigation include: 15% Trichloroacetic acid + 3% glycolic acid (DRUG).
Who is sponsoring clinical trial NCT05471947?
This trial is sponsored by Main Line Center for Laser Surgery, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.